RCKT - Rocket Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RCKT is currently covered by 12 analysts with an average price target of $21.56. This is a potential upside of $18.08 (519.54%) from yesterday's end of day stock price of $3.48.

Rocket Pharmaceuticals's activity chart (see below) currently has 130 price targets and 125 ratings on display. The stock rating distribution of RCKT is 70% BUY and 30% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 23.62% with an average time for these price targets to be met of 112.21 days.

Highest price target for RCKT is $32, Lowest price target is $2.5, average price target is $10.28.

Most recent stock forecast was given by ERIC JOSEPH from JPMORGAN on 18-Nov-2025. First documented stock forecast 20-Sep-2016.

Currently out of the existing stock ratings of RCKT, 21 are a BUY (70%), 9 are a HOLD (30%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

1 months 8 days ago
(18-Nov-2025)

3/6 (50%)

$33.87 (168.26%)

227

Buy

$11

$7.58 (221.64%)

$11

2 months 12 days ago
(14-Oct-2025)

3/13 (23.08%)

$6.73 (157.61%)

140

Hold

$7

$3.58 (104.68%)

$8

2 months 23 days ago
(03-Oct-2025)

1/11 (9.09%)

$3.85 (122.22%)

374

Hold

$4

$0.58 (16.96%)

$9

5 months 1 days ago
(25-Jul-2025)

2/6 (33.33%)

$0.86 (27.39%)

113

Buy

$10

$6.58 (192.40%)

$11

5 months 1 days ago
(25-Jul-2025)

0/10 (0%)

$6.86 (218.47%)

Show more analysts

Please expand the browser size to see the chart

What is RCKT (Rocket Pharmaceuticals) average time for price targets to be met?

On average it took 112.21 days on average for the stock forecasts to be realized with a an average price target met ratio 23.62

Which analyst has the current highest performing score on RCKT (Rocket Pharmaceuticals) with a proven track record?

ESTHER RAJAVELU

Which analyst has the most public recommendations on RCKT (Rocket Pharmaceuticals)?

Esther Rajavelu has 4 price targets and 3 ratings on RCKT

Which analyst is the currently most bullish on RCKT (Rocket Pharmaceuticals)?

Corey Davis with highest potential upside - $84.58

Which analyst is the currently most reserved on RCKT (Rocket Pharmaceuticals)?

Andrew Tsai with lowest potential downside - -$0.92

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?